financetom
Business
financetom
/
Business
/
Novo Nordisk President to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk President to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices
Jun 11, 2024 10:14 AM

12:46 PM EDT, 06/11/2024 (MT Newswires) -- US Sen. Bernie Sanders, chairman of the Senate Committee on Health, Education, Labor, and Pensions, said Tuesday the committee will vote on June 18 to subpoena Novo Nordisk's ( NVO ) President Doug Langa to testify about the prices of diabetes and weight-loss drugs Ozempic and Wegovy in the US.

The committee's investigation found that Novo Nordisk ( NVO ) charges $969 per month for Ozempic and $1,349 a month for Wegovy in the US, dwarfing prices in Germany, Denmark and Canada, Sanders said.

Novo Nordisk ( NVO ) did not immediately respond to MT Newswires' request for comment.

Price: 141.74, Change: -1.89, Percent Change: -1.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved